News 

 

Click on our social media addresses to see news from Menarini Turkey.

 

icone_facebook   icone_instagram   icone_twitter   icone_linkedin   icona_youtube

 


Menarini Group and Radius Health Announce Positive Phase 3 Topline Results from the EMERALD Trial Evaluating Elacestrant in Breast Cancer

Florence, Italy and Boston, Mass., October 20, 2021 – the Menarini Group (“Menarini”) and Radius Health, Inc. (“Radius”) (NASDAQ: RDUS) (collectively, the “Companies”) today announced positive topline results from the EMERALD study.

Menarini Pills of Art Junior project launched, video clips made by the younger generations for children and teenagers

Florence, Italy, 9th April 2021. “Who are the people depicted in the Primavera and why are they dancing in an orchard instead of a ballroom? “or “ Why was the Medusa painted on a shield?” These are just some of the questions posed

CHMP Adopted Positive Opinion for ELZONRIS (tagraxofusp), for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

The CHMP recommended approval of ELZONRIS for the first line treatment of adult patients with BPDCN.

Menarini Group: committed to fighting today's COVID-19 pandemic with an eye to averting similar health crises in the future

Menarini Group and Radius Health Announce Global License Agreement for the Development and Commercialization of Elacestrant

WALTHAM, Mass. – Florence, Italy, July 23, 2020

Menarini Turkey
History

The story of İbrahim Etem which started in a small laboratory a hundred ago...

Menarini Turkey
About Us

Our vision is to produce "value" for human ...

Menarini Turkey
Values

To discover our priorities and the meaning of our values...

Menarini
in the World

To see the activities of the Menarini Group in other countries.
Scroll Top